関連する実験動画
Updated: Aug 16, 2026

23:06
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
バングラデシュの地域保健医療従事者による結核の管理
A M Chowdhury1, S Chowdhury, M N Islam
1BRAC, Dhaka, Bangladesh. red@amrbrac.bdmail.net
Lancet (London, England)
|July 19, 1997
まとめ
ブラク (BRAC) とは
科学分野:
- 公衆衛生は公衆衛生である.
- 感染症のコントロール・コントロール
- グローバル・ヘルス グローバル・ヘルス
背景:
- 結核 (TB) は,バングラデシュで重大な公衆衛生上の課題となっています.
- 国内での結核対策の取り組みは,症例の検出と治療の順守において課題に直面しています.
- BRACは1984年にコミュニティベースの結核管理プログラムを開始し,複数の段階を経て進化しました.
研究 の 目的:
- BRACのコミュニティベースの結核対策プログラムの有効性を評価する.
- 症例検知率,治療順守,患者のアウトカムを評価する.
- プログラム地域における結核の罹患率と,プログラム以外の地域における結核の罹患率を比較する.
主な方法:
- 1992年から1995年にかけてのプログラムデータを分析し,12ヶ月と8ヶ月間の治療を対象とした.
- 治療結果の別々の分析 (治癒,死亡,失敗,デフォルト,移行,推薦) を異なるフェーズで行う.
- ランダムに選択された世帯の横断調査により,結核の罹患率を決定し,プログラムと非プログラム領域を比較します.
主要な成果:
- 高い治療受容率: 12ヶ月の治療では90%,8ヶ月の治療では100%です.
- 81.0% (12ヶ月) と85.9% (8ヶ月) の治癒率を達成しました.
- プログラム地域における結核の罹患率は,プログラム以外の比較地域 (0.07対0.15/100) の半分であった.
結論:
- BRACの結核対策プログラムは,高い症例の検出と治療順守において成功を収めている.
- 治癒率は85%を超え,中退率は3.1%と低い.
- このプログラムは結核の罹患率を効果的に低下させ,既存の症例の少なくとも半分が発見されたことを示唆しています.
キーワード:
アジア アジア アジアバングラデシュ バングラデシュ バングラデシュ バングラデシュ バングラデシュ バングラデシュ バングラデシュ伝染病のコントロール・コントロールコミュニティ・ワーカー--女性保健医療の提供について発展途上国 開発途上国病気 病気 病気ドラッグ ドラッグ ドラッグ経済的な要因 経済的な要因健康 健康 健康 健康とは医療スタッフ 医療スタッフ医療サービス 健康サービス感染症 感染症低所得者集団 低所得者集団非政府機関 非政府機関組織と管理 組織と管理組織 組織 組織 組織プログラムの有効性 プログラムの有効性プログラム評価プログラムプログラム プログラム プログラム社会階級 社会階級社会経済的要因 社会経済的要因社会経済的地位 社会経済的地位南アジア 南アジア 南アジアトリートメント 治療法結核 - 予防と制御さらに関連する動画
関連する概念動画
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

